Broadcom vs. Taiwan Semiconductor: Which AI Chip Giant Is the Better Buy Right Now?

Broadcom’s AI semiconductor revenue jumped 106% year over year to $8.4 billion in fiscal Q1, with management guiding to about $10.7 billion next quarter and citing visibility to more than $100 billion of AI chip revenue in 2027. Taiwan Semiconductor also posted strong AI-linked results, with revenue up 40.6% year over year and its high-performance computing platform rising to 61% of sales, while raising full-year 2026 growth guidance to more than 30%. The piece is ultimately bullish on Broadcom versus TSMC, though it notes valuation, customer concentration, and Taiwan geopolitical risk.

Analysis

The market is pricing AVGO and TSM as generic AI beneficiaries, but the earnings quality is diverging in a way that matters for factor performance. AVGO is becoming a pure-play AI supply bottleneck with backlog visibility that can support multiple quarters of estimate revisions, while TSM is the lower-beta toll booth on the entire AI capex cycle with less upside convexity but better durability. In practice, that means AVGO should trade more like a backlog-driven growth compounder, while TSM should be valued more like an indispensable infrastructure utility with cyclical insulation from non-AI end markets.

The second-order winner is not just hyperscalers; it is the ecosystem attached to custom silicon design and advanced packaging. As AVGO ramps custom accelerators, demand should stay tight for leading-edge wafer starts, advanced packaging, and high-speed interconnect, which should continue to lift the entire AI supply chain and keep smaller foundry-adjacent names levered to the same cycle. Conversely, any slowdown in hyperscaler spending would hit AVGO faster than TSM because AVGO's concentration is an asset until it isn't.

The key risk is timing mismatch: the market may be extrapolating 2027 AI targets into 2026 multiples before those revenues are fully de-risked. If one or two hyperscaler projects slip, AVGO's premium can compress quickly because the stock already discounts near-term perfection, whereas TSM has more earnings ballast from diversified manufacturing demand. On the other side, TSM's geopolitical risk remains a structural discount, but that discount may be too static if the company continues compounding margins and AI mix; the market could re-rate the name if investors start viewing it as the cleanest way to own AI capex without customer-concentration risk.

Contrarian view: the obvious consensus is overweight AVGO because the growth is more explicit, but the better risk-adjusted setup may still be TSM on pullbacks. The market is paying for certainty in AVGO, yet the real asymmetry may come from a TSM multiple expansion if AI stays strong while smartphones and other end markets stabilize. That makes this less a binary 'which AI winner' call and more a question of whether investors want higher beta on execution visibility or lower beta on duration of the AI buildout.

Key Decisions for Investors

• Long AVGO / short TSM for 1-3 months into the next earnings cycle if you want to express accelerating AI revenue visibility; risk is multiple compression if backlog-to-revenue conversion disappoints.
• If entering AVGO, prefer call spreads over stock: buy 6-9 month upside exposure to capture estimate revisions while defining downside against a crowded valuation base.
• Use TSM as the lower-volatility AI infrastructure long in core portfolios on pullbacks; risk/reward is better for investors prioritizing durability over upside convexity.
• Pair long TSM / short a basket of legacy semiconductor cyclicals (e.g. INTC, weaker analog names) over 6-12 months to isolate AI-led manufacturing share gains versus non-AI end-market weakness.
• Trim AVGO on any sharp post-print gap-up; the stock looks most vulnerable to disappointment once the market fully prices in the 2027 AI target before the revenue stream is actually realized.